Obtain and analyze medical record data on patients with advanced emphysema who receive treatment with the AeriSeal System to better understand safety and effectiveness in the post-market setting;
Provide participating physicians access to specified data sets for the purpose of generating scientific manuscripts about the effects of AeriSeal System treatment.
Enrollment
25 estimated patients
Sex
All
Ages
40+ years old
Volunteers
No Healthy Volunteers
Inclusion criteria
Advanced Emphysema
AeriSeal System treatment
Exclusion criteria
have a primary diagnosis of asthma, chronic bronchitis or bronchiectasis
have had frequent COPD exacerbations within the past year
require mechanical ventilatory support
have a pretreatment DLCO < 20% predicted or > 60% predicted
have a pretreatment FEV1 < 20% predicted AND homogeneous emphysema
have giant bullae
have undergone lung transplantation, lung volume reduction surgery, or lobectomy